Investing Profile

Carl Gordon

VC

orbimed.com/en/leadership

Your Intro Paths to Carl Gordon

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Carl Gordon on

cb

Current Investing Position

OrbiMed Managing Partner

Investment Range

$1M - $75.0M

Sweet Spot

$4.0M

Investments On Record

63

Current Fund Size

$18B

Carl Gordon is on these Sector & Stage Rankings

Medical Devices (Seed)Pharmaceuticals (Seed)Health & Hospital Services (Seed)Medical Devices (Series A)Pharmaceuticals (Series A)Health & Hospital Services (Series A)Medical Devices (Series B)Pharmaceuticals (Series B)Health & Hospital Services (Series B)New York City

Carl Gordon's Investments On Record (30)

Company	StageDateRound Size	Total Raised
Alterome Therapeutics	Series BApr 2024$130M Series ANov 2022$35M Series AJan 2022$64M	$230M
Co-investors: Thilo Schroeder (Nextech Invest), Arjun Goyal (Vida Ventures)
ENYO Pharma	Series CJan 2024$43M Series BJun 2018$47M	$90M
Co-investors: Iain Dukes (OrbiMed), Raphael Wisniewski (Andera Partners)
BlossomHill Therapeutics	Series BJan 2024$100M Series AMar 2021$71M	$170M
Star Therapeutics	Series CSep 2023$90M	$90M
Co-investors: Maha Katabi (Sofinnova Investments), Beth Seidenberg (Westlake Village BioPartners)
ADARx Pharmaceuticals	Series CAug 2023$200M Series BJan 2023$46M Series BSep 2021$75M	$320M
Co-investors: Simeon J. George (SR One), Lorence Kim (Third Rock Ventures)
Garuda Therapeutics	Series BFeb 2023$62M Series ASep 2021$72M	$130M
Co-investors: Eric Aguiar (Aisling Capital), Shaan C. Gandhi (Northpond Ventures)
ArriVent Biopharma	Series BDec 2022$160M	$160M
Co-investors: Elena Viboch (General Catalyst), James Healy (Sofinnova Investments)
MBX Biosciences	Series BNov 2022$120M Series AJul 2020$35M	$150M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Patrick Heron (Frazier Healthcare Partners)

Investors who invest with Carl Gordon

Alexandria Huynh

Charles Steinman